USA - NYSE:CTEV - US62548M2098 - Common Stock
The current stock price of CTEV is 45.28 USD. In the past month the price decreased by -35.92%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 36.73 | 44.85B | ||
| DOCS | DOXIMITY INC-CLASS A | 29.19 | 8.97B | ||
| WAY | WAYSTAR HOLDING CORP | 26.07 | 6.67B | ||
| HTFL | HEARTFLOW INC | N/A | 2.28B | ||
| CERT | CERTARA INC | 16.27 | 1.31B | ||
| SDGR | SCHRODINGER INC | N/A | 1.26B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.24B | ||
| PHR | PHREESIA INC | N/A | 1.17B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.06B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 625.25 | 1.06B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 7.97 | 969.39M | ||
| HSTM | HEALTHSTREAM INC | 36.18 | 729.14M |
Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
CLARITEV CORP
7900 Tysons One Place, Suite 400
McLean VIRGINIA US
Employees: 2700
Phone: 12127802000
Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
The current stock price of CTEV is 45.28 USD. The price increased by 7.07% in the last trading session.
CTEV does not pay a dividend.
CTEV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
CTEV stock is listed on the New York Stock Exchange, Inc. exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CTEV.
The Revenue of CLARITEV CORP (CTEV) is expected to grow by 1.46% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a fundamental rating of 2 / 10 to CTEV. CTEV has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months CTEV reported a non-GAAP Earnings per Share(EPS) of -20.48. The EPS increased by 67.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.07% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
9 analysts have analysed CTEV and the average price target is 78.2 USD. This implies a price increase of 72.7% is expected in the next year compared to the current price of 45.28.
For the next year, analysts expect an EPS growth of 77.63% and a revenue growth 1.46% for CTEV